drugset / Trial / NCT05945160
Vestibular Function Using Mitochondrial Antioxidant Therapy
Phase 0
Withdrawn
The University of Texas Health Science Center at San Antonio
National Institute on Aging (NIA) · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
To determine if supplementation with known mitochondrial antioxidants (alpha lipoic acid (ALA) and CoQ-10) will stabilize or improve vestibular function in older adults.
Timeline
- Start
- 2024-01
- Primary completion
- 2024-08
- Completion
- 2024-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Coenzyme Q10 | Other / unclassified | 200 mg | — |
| Subject | alpha-lipoic acid | Small molecule | 300 mg | — |